S&P 500   4,252.94 (-0.83%)
DOW   33,211.54 (-0.66%)
QQQ   359.49 (-0.49%)
AAPL   173.52 (-0.13%)
MSFT   320.27 (-0.48%)
META   305.47 (-0.44%)
GOOGL   133.80 (-0.28%)
AMZN   127.55 (-1.48%)
TSLA   248.92 (-1.07%)
NVDA   448.80 (+0.22%)
NIO   8.69 (-1.14%)
BABA   84.58 (-2.25%)
AMD   102.75 (-0.50%)
T   14.78 (+0.75%)
F   12.22 (-0.73%)
MU   69.54 (+2.32%)
CGC   0.73 (-1.33%)
GE   109.71 (+0.85%)
DIS   81.71 (+0.05%)
AMC   8.26 (+1.35%)
PFE   34.02 (+0.24%)
PYPL   58.46 (-0.17%)
NFLX   386.82 (+1.71%)
S&P 500   4,252.94 (-0.83%)
DOW   33,211.54 (-0.66%)
QQQ   359.49 (-0.49%)
AAPL   173.52 (-0.13%)
MSFT   320.27 (-0.48%)
META   305.47 (-0.44%)
GOOGL   133.80 (-0.28%)
AMZN   127.55 (-1.48%)
TSLA   248.92 (-1.07%)
NVDA   448.80 (+0.22%)
NIO   8.69 (-1.14%)
BABA   84.58 (-2.25%)
AMD   102.75 (-0.50%)
T   14.78 (+0.75%)
F   12.22 (-0.73%)
MU   69.54 (+2.32%)
CGC   0.73 (-1.33%)
GE   109.71 (+0.85%)
DIS   81.71 (+0.05%)
AMC   8.26 (+1.35%)
PFE   34.02 (+0.24%)
PYPL   58.46 (-0.17%)
NFLX   386.82 (+1.71%)
S&P 500   4,252.94 (-0.83%)
DOW   33,211.54 (-0.66%)
QQQ   359.49 (-0.49%)
AAPL   173.52 (-0.13%)
MSFT   320.27 (-0.48%)
META   305.47 (-0.44%)
GOOGL   133.80 (-0.28%)
AMZN   127.55 (-1.48%)
TSLA   248.92 (-1.07%)
NVDA   448.80 (+0.22%)
NIO   8.69 (-1.14%)
BABA   84.58 (-2.25%)
AMD   102.75 (-0.50%)
T   14.78 (+0.75%)
F   12.22 (-0.73%)
MU   69.54 (+2.32%)
CGC   0.73 (-1.33%)
GE   109.71 (+0.85%)
DIS   81.71 (+0.05%)
AMC   8.26 (+1.35%)
PFE   34.02 (+0.24%)
PYPL   58.46 (-0.17%)
NFLX   386.82 (+1.71%)
S&P 500   4,252.94 (-0.83%)
DOW   33,211.54 (-0.66%)
QQQ   359.49 (-0.49%)
AAPL   173.52 (-0.13%)
MSFT   320.27 (-0.48%)
META   305.47 (-0.44%)
GOOGL   133.80 (-0.28%)
AMZN   127.55 (-1.48%)
TSLA   248.92 (-1.07%)
NVDA   448.80 (+0.22%)
NIO   8.69 (-1.14%)
BABA   84.58 (-2.25%)
AMD   102.75 (-0.50%)
T   14.78 (+0.75%)
F   12.22 (-0.73%)
MU   69.54 (+2.32%)
CGC   0.73 (-1.33%)
GE   109.71 (+0.85%)
DIS   81.71 (+0.05%)
AMC   8.26 (+1.35%)
PFE   34.02 (+0.24%)
PYPL   58.46 (-0.17%)
NFLX   386.82 (+1.71%)
NASDAQ:ZIVO

ZIVO Bioscience (ZIVO) Stock Forecast, Price & News

$1.22
-0.06 (-4.69%)
(As of 08:00 AM ET)
Compare
Today's Range
$1.22
▼
$1.22
50-Day Range
$1.18
▼
$2.09
52-Week Range
$1.10
▼
$3.75
Volume
100 shs
Average Volume
11,886 shs
Market Capitalization
$12.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
ProfileAnalyst RatingsChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

ZIVO Bioscience MarketRank™ Forecast

Analyst Rating
0.00 Rating Score
Upside/​Downside
368.8% Upside
$6.00 Price Target
Short Interest
Healthy
0.69% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.07 out of 5 stars

Medical Sector

559th out of 975 stocks

Biological Products, Except Diagnostic Industry

83rd out of 158 stocks

See Top Rated MarketRank™ Stocks Here

ZIVO stock logo

About ZIVO Bioscience (NASDAQ:ZIVO) Stock

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

ZIVO Price History

ZIVO Stock News Headlines

October 3, 2023 | finance.yahoo.com
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
September 19, 2023 | finance.yahoo.com
Trial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
October 3, 2023 | Edge On The Street (Ad)
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
August 16, 2023 | businesswire.com
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife ™ Algal Biomass Product Produced Over the Next 18 Months
August 16, 2023 | marketwatch.com
Zivo Bioscience: ZWorldwide to Buy All Zivolife Supply for First 18 Months of Agreement
August 16, 2023 | finance.yahoo.com
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 Months
July 26, 2023 | finance.yahoo.com
ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food
June 29, 2023 | marketwatch.com
Zivo Bioscience Shares Jump Premarket After Dropping Plans for Securities Offering
October 3, 2023 | Edge On The Street (Ad)
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
May 30, 2023 | benzinga.com
ZIVO's GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient
May 30, 2023 | finance.yahoo.com
ZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient
May 10, 2023 | investing.com
SK Bioscience Co Ltd (302440)
April 5, 2023 | msn.com
Zivo Bioscience gets $1M loan from CEO
March 17, 2023 | markets.businessinsider.com
Maxim Group Keeps Their Buy Rating on Zivo Bioscience (ZIVO)
February 10, 2023 | marketwatch.com
Zivo Bio Shares Slide 23% on High Mortality Rate in Coccidiosis Treatment Study
February 10, 2023 | marketwatch.com
Stocks to Watch: Blue Apron, Zivo Bioscience, Berkshire Grey
February 10, 2023 | markets.businessinsider.com
ZIVO Reports Negative Results Of Study With Product Candidate For Coccidiosis Treatment In Chickens
January 29, 2023 | seekingalpha.com
Pressure BioSciences, One World team up to develop CBD sports performance drinks
October 25, 2022 | finance.yahoo.com
ZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech Business
September 23, 2022 | finance.yahoo.com
ZIVO Bioscience CEO Issues Letter to Shareholders
September 16, 2022 | finance.yahoo.com
ZIVO Bioscience, Inc. (ZIVO)
August 10, 2022 | finance.yahoo.com
ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment
June 27, 2022 | finance.yahoo.com
Zivo Bioscience Joins Russell Microcap® Index
April 25, 2022 | seekingalpha.com
ZIVO Bioscience regains compliance with Nasdaq continued listing rule
April 25, 2022 | apnews.com
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq
January 10, 2022 | seekingalpha.com
ZIVO Bioscience names John Payne as president, CEO
January 10, 2022 | finance.yahoo.com
ZIVO Bioscience Names Chairman John B. Payne as President and CEO
See More Headlines
Receive ZIVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

ZIVO Company Calendar

Last Earnings
5/11/2020
Today
10/03/2023
Next Earnings (Estimated)
10/05/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ZIVO
Previous Symbol
OTCMKTS:HEPI
CUSIP
N/A
CIK
1101026
Web
www.zivobioscience.com
Phone
(248) 452-9866
Fax
N/A
Employees
8
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.00
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+368.8%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,740,000.00
Net Margins
N/A
Pretax Margin
-214,543.19%
Return on Equity
-1,249.74%
Return on Assets
-438.17%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.14
Quick Ratio
0.14

Sales & Book Value

Annual Sales
$20,000.00
Price / Sales
668.80
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
10,450,000
Free Float
9,050,000
Market Cap
$13.38 million
Optionable
Not Optionable
Beta
0.24
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. John B. Payne (Age 75)
    Pres, CEO & Chairman
    Comp: $572.75k
  • Mr. Keith R. Marchiando (Age 61)
    CFO, Treasurer & Sec.
    Comp: $362.5k
  • Dr. Harlan L. Miller III
    VP of Technology & Global Supply

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













ZIVO Stock - Frequently Asked Questions

What is ZIVO Bioscience's stock price forecast for 2023?

0 analysts have issued twelve-month price targets for ZIVO Bioscience's stock. Their ZIVO share price forecasts range from $6.00 to $6.00. On average, they predict the company's stock price to reach $6.00 in the next year. This suggests a possible upside of 368.8% from the stock's current price.
View analysts price targets for ZIVO or view top-rated stocks among Wall Street analysts.

How have ZIVO shares performed in 2023?

ZIVO Bioscience's stock was trading at $2.50 at the beginning of 2023. Since then, ZIVO shares have decreased by 48.8% and is now trading at $1.28.
View the best growth stocks for 2023 here.

When is ZIVO Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 5th 2023.
View our ZIVO earnings forecast.

How were ZIVO Bioscience's earnings last quarter?

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) released its quarterly earnings data on Monday, May, 11th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The biotechnology company earned $0.02 million during the quarter.

What is ZIVO Bioscience's stock symbol?

ZIVO Bioscience trades on the NASDAQ under the ticker symbol "ZIVO."

How do I buy shares of ZIVO Bioscience?

Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ZIVO Bioscience's stock price today?

One share of ZIVO stock can currently be purchased for approximately $1.28.

How much money does ZIVO Bioscience make?

ZIVO Bioscience (NASDAQ:ZIVO) has a market capitalization of $13.38 million and generates $20,000.00 in revenue each year.

How can I contact ZIVO Bioscience?

ZIVO Bioscience's mailing address is 2804 ORCHARD LAKE ROAD SUITE 202, KEEGO HARBOR MI, 48320. The official website for the company is www.zivobioscience.com. The biotechnology company can be reached via phone at (248) 452-9866 or via email at investor@zivobioscience.com.

This page (NASDAQ:ZIVO) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -